118 related articles for article (PubMed ID: 2423783)
1. Preliminary observations of chronic indoramin therapy in congestive heart failure.
Leier CV; Huss P; Parrish D; Binkley PF; Unverferth DV
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S112-6. PubMed ID: 2423783
[TBL] [Abstract][Full Text] [Related]
2. Long-term indoramin therapy in congestive heart failure: a double-blind, randomized, parallel placebo-controlled trial.
Leier CV; Binkley PF; Randolph PH; Unverferth DV
J Am Coll Cardiol; 1987 Feb; 9(2):426-32. PubMed ID: 3543093
[TBL] [Abstract][Full Text] [Related]
3. Indoramin in severe congestive heart failure.
Grube E; Manz M; Lüderitz B
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S117-23. PubMed ID: 2423784
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic responses to indoramin at rest and during exercise in congestive heart failure.
Leier CV; Majetich N; Binkley PF; Uverferth DV
Pharmacotherapy; 1987; 7(3):61-8. PubMed ID: 3628063
[TBL] [Abstract][Full Text] [Related]
5. Indoramin in heart failure: possible adverse effects on hemodynamics and exercise capacity.
Seth L; Galiè N; Casebolt P; Gimenez H; Malloy M; Franciosa JA
Clin Pharmacol Ther; 1986 Nov; 40(5):567-74. PubMed ID: 3769387
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of intravenous indoramin on the hemodynamic adaptation at rest and during exercise in chronic congestive heart failure.
De Kock MR; Detry JM
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S107-11. PubMed ID: 2423782
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic dose-response effects of intravenous indoramin in acute heart failure complicating myocardial infarction.
Silke B; Nelson GI; Verma SP; Frais MA; Reynolds G; Jackson N; Taylor SH
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S102-6. PubMed ID: 2423781
[TBL] [Abstract][Full Text] [Related]
8. Acute hemodynamic and hormonal response to indoramin in congestive heart failure.
Olivari MT; Garberg VR; Selby T; Cohn JN; Levine TB
Clin Pharmacol Ther; 1984 Sep; 36(3):297-301. PubMed ID: 6380878
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure.
Good AP; Unverferth DV; Leier CV
Cardiovasc Drugs Ther; 1988 Jan; 1(5):529-34. PubMed ID: 2908715
[TBL] [Abstract][Full Text] [Related]
10. The effect of indoramin on exercise performance in mild hypertension.
Bishop N; Mackintosh AF; Stoker JB; Mary DA; Linden RJ
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S30-6. PubMed ID: 2423794
[TBL] [Abstract][Full Text] [Related]
11. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
[TBL] [Abstract][Full Text] [Related]
12. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure.
Franciosa JA; Cohn JN
Am J Cardiol; 1979 May; 43(5):1009-14. PubMed ID: 433762
[TBL] [Abstract][Full Text] [Related]
13. Effect of indoramin and propranolol on cardiovascular response to cold in hypertensive patients.
Velasco M; Urbina-Quintana A; Andrews-Figueroa P; Nieves D; Hernández E; Guevara-Casado J; Hernández-Pieretti O
Clin Pharmacol Ther; 1982 Jul; 32(1):7-11. PubMed ID: 7083732
[TBL] [Abstract][Full Text] [Related]
14. Antianginal and haemodynamic effects of alpha 1-adrenoceptor blockade.
Sheridan DJ; Thomas P; Culling W; Collins P
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S144-50. PubMed ID: 2423788
[TBL] [Abstract][Full Text] [Related]
15. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
Leier CV; Huss P; Magorien RD; Unverferth DV
Circulation; 1983 Apr; 67(4):817-22. PubMed ID: 6337742
[TBL] [Abstract][Full Text] [Related]
16. [Indoramin in severe cardiac insufficiency. Acute hemodynamic effectiveness].
Grube E; Lauven GW; Manz M; Lüderitz B
Dtsch Med Wochenschr; 1986 Mar; 111(11):416-20. PubMed ID: 3948703
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial.
Marcus LS; Hart D; Packer M; Yushak M; Medina N; Danziger RS; Heitjan DF; Katz SD
Circulation; 1996 Dec; 94(12):3184-9. PubMed ID: 8989127
[TBL] [Abstract][Full Text] [Related]
18. Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial.
Franciosa JA; Jordan RA; Wilen MM; Leddy CL
Circulation; 1984 Jul; 70(1):63-8. PubMed ID: 6373050
[TBL] [Abstract][Full Text] [Related]
19. Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.
Jordan RA; Seith L; Henry DA; Wilen MM; Franciosa JA
Circulation; 1985 May; 71(5):980-6. PubMed ID: 3921279
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute and chronic minoxidil administration on rest and exercise hemodynamics and clinical status in patients with severe, chronic heart failure.
Nathan M; Rubin SA; Siemienczuk D; Swan HJ
Am J Cardiol; 1982 Nov; 50(5):960-6. PubMed ID: 7137047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
